Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Apple
AAPL
|
+$273M |
| 3 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$254M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$250M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$406M |
| 2 |
Automatic Data Processing
ADP
|
+$357M |
| 3 |
AABA
Altaba Inc
AABA
|
+$313M |
| 4 |
Meta Platforms (Facebook)
META
|
+$278M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$263M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.08% |
| 2 | Technology | 5.04% |
| 3 | Consumer Discretionary | 3.4% |
| 4 | Energy | 3.22% |
| 5 | Healthcare | 3.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Novavax
NVAX
$1.26B
| $982K | ﹤0.01% |
36,666
-9,634
| -21% | -$326K |
|
3327
CALL
Idexx Laboratories
IDXX
$46.4B
| $981K | ﹤0.01% |
4,500
+2,500
| +125% | +$515K |
|
|
MDCO
3328
CALL
DELISTED
Medicines Co
MDCO
| $980K | ﹤0.01% |
26,700
+22,000
| +468% | +$715K |
|
3329
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $979K | ﹤0.01% |
50,810
+6,400
| +14% | +$123K |
|
3330
Genesco
GCO
$439M
| $978K | ﹤0.01% |
24,646
-8,254
| -25% | -$352K |
|
3331
TTEC Holdings
TTEC
$132M
| $978K | ﹤0.01% |
28,312
-1,337
| -5% | -$45.3K |
|
|
CPE
3332
DELISTED
Callon Petroleum Company
CPE
| $977K | ﹤0.01% |
9,104
-37,956
| -81% | -$4.71M |
|
3333
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.46B
| $976K | ﹤0.01% |
44,321
-608
| -1% | -$14.2K |
|
3334
Integra LifeSciences
IART
$1.39B
| $976K | ﹤0.01% |
15,160
+4,161
| +38% | +$258K |
|
|
ORIT
3335
DELISTED
Oritani Financial Corp. New
ORIT
| $976K | ﹤0.01% |
60,299
+47,574
| +374% | +$751K |
|
3336
iShares US Technology ETF
IYW
$25.1B
| $972K | ﹤0.01% |
21,812
+2,864
| +15% | +$127K |
|
3337
PUT
Alerian MLP ETF
AMLP
$12.9B
| $971K | ﹤0.01% |
19,220
+5,460
| +40% | +$277K |
|
|
GTHX
3338
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $969K | ﹤0.01% |
22,301
+20,318
| +1,025% | +$871K |
|
3339
Sprouts Farmers Market
SFM
$8.03B
| $968K | ﹤0.01% |
43,834
-258
| -0.6% | -$5.84K |
|
3340
PUT
Children's Place
PLCE
$59.2M
| $966K | ﹤0.01% |
8,000
-500
| -6% | -$64.8K |
|
3341
CALL
Protolabs
PRLB
$2.11B
| $963K | ﹤0.01% |
8,100
+6,400
| +376% | +$784K |
|
|
RPT
3342
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $963K | ﹤0.01% |
72,872
+3,374
| +5% | +$41.2K |
|
|
MNTA
3343
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $963K | ﹤0.01% |
47,113
-18,071
| -28% | -$388K |
|
3344
Ericsson
ERIC
$33.7B
| $962K | ﹤0.01% |
125,359
+46,606
| +59% | +$341K |
|
3345
PUT
Dave & Buster's
PLAY
$369M
| $962K | ﹤0.01% |
20,200
+13,800
| +216% | +$611K |
|
|
UNT
3346
DELISTED
UNIT Corporation
UNT
| $962K | ﹤0.01% |
37,648
+10,941
| +41% | +$242K |
|
3347
CALL
First Majestic Silver
AG
$8.13B
| $961K | ﹤0.01% |
126,000
+11,400
| +10% | +$79.8K |
|
3348
Graco
GGG
$13.3B
| $961K | ﹤0.01% |
21,248
-52,229
| -71% | -$2.4M |
|
3349
Liberty Broadband Class C
LBRDK
$5.17B
| $960K | ﹤0.01% |
12,674
+2,252
| +22% | +$171K |
|
3350
PUT
WisdomTree
WT
$3.42B
| $960K | ﹤0.01% |
105,700
-21,300
| -17% | -$222K |
|
Similar funds
Citigroup's Q2 2018 Portfolio in Review
As of Q2 2018, Citigroup held 7,964 positions worth $109B, down 10% from $121B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup withdrew a net $16.6B in Q2 2018, closing 306 positions and reducing 3,274 holdings. Its most notable exit was Monsanto Co, an estimated $159M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5.1% of assets, up from 4.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Global X Artificial Intelligence & Technology ETF worth $40.8M.
- Citigroup's largest Q2 2018 buy was Global X Artificial Intelligence & Technology ETF: 2,719,000 shares worth $40.8M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.04B increase.
- Citigroup's biggest Q2 2018 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $406M.
- Citigroup fully exited Monsanto Co in Q2 2018, selling an estimated $159M.
- Citigroup's ten largest holdings make up 24% of its $109B portfolio in Q2 2018.
- Citigroup opened 380 new positions and closed 306 in Q2 2018.
- Citigroup's portfolio value fell 10% quarter-over-quarter to $109B.
Based on Citigroup's 13F filing for Q2 2018, filed 10 Aug 2018.